Progenics Pharma (PGNX) Announces CMS Grants New Technology Add-On Payment for Inpatient Use of AZEDRA

August 6, 2019 8:39 AM
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), an oncology company developing innovative targeted medicines and artificial intelligence to find, fight and follow ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles